Active ingredient
AMIVANTAMAB
Registration activity, product holders, and manufacturers linked to this active ingredient in the AIPHARM dataset.
Registered products
1
Top manufacturer
Not available
Top holder
JOHNSON & JOHNSON SDN. BHD.
Updated
22 May 2026
Overview
Product registrations over time
Latest visible period: 2026-05-22
Analysis
Companies connected to this ingredient
Analysis
Product Manufacturer
| Manufacturer name | Product count |
|---|---|
| No data available | |
No data available
Analysis
Product Holder
| Product holder name | Product count |
|---|---|
| 1 |
Product count1
Rows per page:
1–1 of 1
Listing
Registered Product
| Product name | Product Reg. no | Type | Product Holder | Manufacturer | Importer | Registration Status |
|---|---|---|---|---|---|---|
| RYBREVANT 350mg/7mL Concentrate for Solution for Infusion | MAL22116003AZ | BIOLOGICS | JOHNSON & JOHNSON SDN. BHD. | Cilag AG | JOHNSON & JOHNSON SDN. BHD. | CONDITIONAL REGISTRATION |
RYBREVANT 350mg/7mL Concentrate for Solution for Infusion
Product Reg. noMAL22116003AZ
TypeBIOLOGICS
Product HolderJOHNSON & JOHNSON SDN. BHD.
ManufacturerCilag AG
ImporterJOHNSON & JOHNSON SDN. BHD.
Registration StatusCONDITIONAL REGISTRATION
Rows per page:
1–1 of 1